Physician profile
Mori Krantz
NPI 1922016088
$22,113.74
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2022: $9,831 · 2023: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,760.00 |
| Food and Beverage | $146.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $11,760.00 | 2023 | |
| Ardelyx, INC. | $9,750.00 | 2022 | |
| Heartflow, INC. | $208.08 | 2019-2022 | |
| Boston Scientific Corporation | $195.81 | 2019 | |
| Amarin Pharma, INC. | $119.70 | 2023 | |
| Biotronik INC. | $41.25 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $26.90 | 2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $12.00 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mori Krantz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.